PHARMACEUTICAL BIOLOGICAL PREPARATIONS UTILIZING

Brand Owner Address Description
XEQUEL Xequel Bio, Inc. 1501 Belle Isle Ave. Mount Pleasant SC 29464 pharmaceutical and biological preparations utilizing aCT1 peptide to restore Connexin43 protein junction integrity in cells, namely, ophthalmic eye drops useful in treating corneal injuries or ocular injury due to chemical agents, dermatological topical formulations useful in treating cutaneous radiation injuries, cutaneous scarring, and thermal burns, and inhalation solutions useful in treating acute lung injuries;SEQUEL;biopharmaceutical research and development services utilizing aCT1 peptide to restore Connexin43 protein junction integrity in cells, in the fields of dermatology, ophthalmology, and pulmonology;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. The invention provides compositions, pharmaceutical preparations and methods for inhibition of cystic fibrosis transmembrane conductance regulator protein (CFTR) that are useful for treating secretory diarrhea. The compositions and pharmaceutical preparations of the invention may comprise one or more thiazolidinone compounds, and may additionally comprise one or more pharmaceutically acceptable carriers, excipients, and/or diluents.